Florida Eye Microsurgical Inst is categorized under Clinics in North Palm Beach, FL .
Florida Eye Microsurgical Inst was established in 0, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Jason Fewer, Administrator at the company’s single location by writing to 13901 Us Highway 1 # 7, North Palm Beach, Florida FL 33408 or by phoning (561) 748-8230. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Florida Eye Microsurgical Inst |
Contact Person: | Jason Fewer, Administrator |
Address: | 13901 Us Highway 1 # 7, North Palm Beach, Florida 33408 |
Phone Number: | (561) 748-8230 |
Website Address: | fleyedocs.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Clinics |
SIC Code: | 8011 |
NAICS Code: | 6214930 |
Share This Business: |
Florida Eye Microsurgical Inst was started in 0 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Jason Fewer, Administrator for inquiries that concern Florida Eye Microsurgical Inst by calling the company number (561) 748-8230, as your correspondence is most welcome. Additionally, the physical location of the single location of Florida Eye Microsurgical Inst can be found at the coordinates 26.880217,-80.055968 as well as the street address 13901 Us Highway 1 # 7 in North Palm Beach, Florida 33408.
For its online presence, you may visit Florida Eye Microsurgical Inst’s website at fleyedocs.com and engage with its social media outlets through on Twitter and on Facebook.